Express Pharma

Share The Department of Pharmaceuticals (DoP) has notified the Drugs (Prices Control) Amendment Order, 2026, introducing a series of amendments to the Drugs (Prices Control) Order (DPCO), 2013 aimed at improving regulatory clarity, easing compliance for pharmaceutical manufacturers and strengthening monitoring under the price control regime. The amendments came into effect on June 30, 2026.

Share The pharmaceutical industry has traditionally regarded packaging as the final stage of manufacturing—a necessary component that protects the product, preserves its quality and facilitates distribution. However, healthcare systems worldwide are increasingly recognising that packaging performs a far more significant function.

Share The Ministry of Health and Family Welfare has released the draft National Pharmacy Commission (NPC) Bill, 2026 for public consultation, proposing a comprehensive overhaul of India’s pharmacy education and professional regulatory framework by replacing the nearly eight-decade-old Pharmacy Act, 1948.

Share Glenmark Specialty S.A, a wholly owned subsidiary of Glenmark Pharmaceuticals (Glenmark) announced the advancement of its multi-country Phase 3 clinical trial for Trastuzumab rezetecan (SHR-A1811), a HER2-targeted antibody drug conjugate (ADC), for patients with platinum-resistant ovarian cancer (PROC).

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry.

Share Roche today announced its second Digital Tech Hub in India, expanding its global Technology Hub network to Hyderabad alongside its existing site in Pune. The new Tech Hub will be going live in the first quarter of 2027 and plans to scale up over the next few years. “Hyderabad is a destination for an exceptional talent pool, especially for the Pharmaceutical and Life Sciences domain,” said Ramesh Durvasula,  Chief Data Officer and Chief AI Officer a.i..

Share Mankind Pharma has announced a strategic collaboration with Denovo Sciences to launch an AI-led drug discovery programme, marking an important step in the company’s focus on innovation-driven and technology-enabled research and development. The partnership will bring together Mankind Pharma’s strong R&D capabilities, experimental validation infrastructure, and clinical development expertise with Denovo Sciences’ proprietary platform for AI-driven molecular generation and prioritization.

Share Cadila Pharmaceuticals, one of India’s leading integrated pharmaceutical companies, and Wellesta Holdings, Singapore, have signed a Memorandum of Understanding (MoU) to establish a strategic Joint Venture aimed at expanding access to high-quality healthcare solutions across South-East Asia and selected international markets. The partnership brings together the complementary strengths of both organisations.

Share Three individuals allegedly bought expired medicines at scrap prices, relabelled them with professionally printed stickers, repackaged them, and pumped them back into the pharmaceutical supply chain. This incident is a stark reminder that expired medicines are not merely a regulatory concern—they are a patient safety hazard. Yet, barely a week later, the Ministry of Health and Family Welfare (MoHFW) proposed making it easier to import medicines much closer to their expiry dates.

Share Morepen Laboratories issued an update on its recently announced Rs. 825 crore CDMO mandate. The first commercial dispatch, valued at approximately Rs. 50 crore, has already been completed by the company under the program during Q1FY2026-27. This marks the successful transition of the mandate from validation and qualification stage to commercial execution stage.